Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Flagship Ventures Fund IV General Partner LLC Insider Profile
11 Followers
Flagship Ventures Fund IV General Partner LLC, Ten Percent Owner at Rubius Therapeutics, holds 7.93M shares in Evelo Biosciences (Ticker: EVLO), holds 29.25M shares in Axcella Health (Ticker: AXLA), holds 17.25M shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Flagship Ventures Fund IV General Partner LLC Bought ― shares of Evelo Biosciences on Jul 13, 2023 for an estimated value of 12.50M.
Flagship Ventures Fund IV General Partner LLC Rubius Therapeutics (RUBY)Ten Percent Owner
Rubius Therapeutics (RUBY)
Ten Percent Owner
Ranked #98,127 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 12 Profitable Transactions
Average Return
-114.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Flagship Ventures Fund IV General Partner LLC's holdings
Insider Roles
Roles that Flagship Ventures Fund IV General Partner LLC holds in companies
Most Profitable Insider Trade
The most profitable trade made by Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV General Partner LLC's Trading History
Rubius Therapeutics
Mar 23, 2021
―
Informative Buy
6.09M
$983.45K
Kaleido Biosciences
Jun 08, 2020
Ten Percent Owner
Informative Buy
15.00M
$1.04M
TransMedics Group
Oct 31, 2019
Ten Percent Owner
Uninformative Sell
―
$7.44M
Axcella Health
Oct 17, 2022
―
Informative Buy
17.03M
$11.70M
Moderna
Aug 19, 2020
Director, Ten Percent Owner
Uninformative Sell
―
$534.37M
Evelo Biosciences
Jul 13, 2023
Ten Percent Owner
Informative Buy
12.50M
$174.52K
Seres Therapeutics
Nov 25, 2020
Ten Percent Owner
Uninformative Sell
―
$2.85M
List of latest transactions for each holding click on a transaction to see Flagship Ventures Fund IV General Partner LLC's performance on stock
You May Also Like
Flagship Ventures Fund IV General Partner LLC insider profile FAQ
What is the percentage of profitable transactions made by Flagship Ventures Fund IV General Partner LLC?
The percentage of profitable transactions made by Flagship Ventures Fund IV General Partner LLC is 8%.
What is the average return per transaction made by Flagship Ventures Fund IV General Partner LLC?
The average return per transaction made by Flagship Ventures Fund IV General Partner LLC is -114.10%.
What stocks does Flagship Ventures Fund IV General Partner LLC hold?
Flagship Ventures Fund IV General Partner LLC holds: RUBY, KLDO, TMDX, AXLA, MRNA, EVLO, MCRB stocks.
What was Flagship Ventures Fund IV General Partner LLC’s latest transaction?
Flagship Ventures Fund IV General Partner LLC latest transaction was an Informative Buy of $12.50M.
What was Flagship Ventures Fund IV General Partner LLC's most profitable transaction?
Flagship Ventures Fund IV General Partner LLC’s most profitable transaction was an Informative Buy of EVLO stock on July 1, 2020. The return on the trade was 178.10%.
What is Flagship Ventures Fund IV General Partner LLC's role in Rubius Therapeutics?
Flagship Ventures Fund IV General Partner LLC's role in Rubius Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.